Financial reports
10-Q
2018 Q3
Quarterly report
14 Nov 18
10-Q
2018 Q2
Quarterly report
14 Aug 18
10-Q
2018 Q1
Quarterly report
15 May 18
10-K
2017 FY
Annual report
2 Apr 18
10-Q
2017 Q3
Quarterly report
14 Nov 17
10-Q
2017 Q2
Quarterly report
14 Aug 17
10-Q
2017 Q1
Quarterly report
15 May 17
10-KT
Annual report (with FYE transition)
17 Apr 17
NT 10-K
Notice of late annual filing
31 Mar 17
10-QT
Quarterly report for transitional period
21 Nov 16
Current reports
8-K
Entry into a Material Definitive Agreement
22 Feb 19
8-K
Departure of Directors or Certain Officers
31 Oct 18
8-K
Dthera Sciences Announces Reverse Split
27 Sep 18
8-K
Entry into a Material Definitive Agreement
20 Sep 18
8-K
Regulation FD Disclosure
23 Aug 18
8-K
Regulation FD Disclosure
6 Aug 18
8-K
Dthera Sciences Closes Private Placement Ahead of Commercial Launch
23 Jul 18
8-K
Departure of Directors or Certain Officers
13 Apr 18
8-K
Unregistered Sales of Equity Securities
21 Feb 18
8-K
Amendments to Articles of Incorporation or Bylaws
23 Oct 17
Registration and prospectus
S-1
IPO registration
27 Sep 18
D
$3M in equity, sold $475K, 2 investors
6 Dec 17
D
$500K in equity, sold $88.04K, 6 investors
1 Sep 17
D
$500K in equity / options, sold $232.11K, 25 investors
3 Aug 17
D
$1.75M in equity, sold $1.24M, 30 investors
17 Apr 17
D
$1 in equity, sold $1, 4 investors
4 Oct 16
D
$240K in debt / options / securities to be acquired / Convertible Note Offering, sold $240K, 4 investors
22 Sep 16
D/A
$120K in equity / options / securities to be acquired / Series A Preferred Shares, sold $30K, 4 investors
15 Jun 16
D
$80K in equity / options / securities to be acquired / Series A Preferred Shares, sold $24.4K, 4 investors
3 Jun 16
D
$3.24K in equity, sold $3.24K, 8 investors
7 Jul 15
Proxies
No filings
Other
SEC STAFF ACTION
SEC staff action: Order
6 Aug 19
UPLOAD
Letter from SEC
4 Dec 18
CORRESP
Correspondence with SEC
19 Nov 18
CORRESP
Correspondence with SEC
9 Nov 18
UPLOAD
Letter from SEC
24 Oct 18
CT ORDER
Confidential treatment order
10 May 18
EFFECT
Notice of effectiveness
13 Feb 14
CORRESP
Correspondence with SEC
10 Feb 14
UPLOAD
Letter from SEC
13 Dec 13
UPLOAD
Letter from SEC
10 Oct 13